Efficacy and Safety of Fostamatinib for Immune Thrombocytopenia in Clinical Practice in Spain: Interim Results of Fostames, Our National Fostamatinib Registry

被引：0

作者：

Jose Gonzalez-Lopez, Tomas ^{[1
]}

Perez Segura, Gloria ^{[2
]}

Domingo, Abel ^{[3
]}

Lopez Ansoar, Elsa ^{[4
]}

Diaz Galvez, Francisco Javier ^{[1
]}

Jimenez Barcenas, Reyes ^{[5
]}

Martinez Carballeira, Daniel ^{[6
]}

De Miguel Llorente, Dunia ^{[7
]}

Perona Blazquez, Alvaro ^{[8
]}

Aguilar-Monserrate, Gerardo ^{[9
]}

Davila-Valls, Julio ^{[10
]}

Gonzalez Gascon, Isabel ^{[11
]}

Cuesta, Amalia ^{[12
]}

Bengochea Casado, Maria Luisa ^{[13
]}

Hermida Fernandez, Gerardo Julio ^{[1
]}

Alonso Alonso, Jose Maria ^{[14
]}

Pozas Manas, Miguel Angel ^{[15
]}

Torres-Tienza, Ana ^{[16
]}

Aguilar, Carlos ^{[17
]}

Fernandez-Jimenez, Dolores ^{[18
]}

Soto, Inmaculada ^{[6
]}

Bernat, Silvia ^{[19
]}

机构：

[1] Hosp Univ Burgos, Burgos, Spain

[2] Hosp Univ 12 Octubre, Madrid, Spain

[3] Fundacio Privada Hosp Asil de Granollers, Granollers, Spain

[4] Hosp Univ Alvaro Cunqueiro, Vigo, Spain

[5] Hosp Serrania Ronda, Malaga, Spain

[6] Hosp Univ Cent Asturias, Oviedo, Asturias, Spain

[7] Hosp Univ Guadalajara, Guadalajara, Spain

[8] Complejo Hosp Univ Albacete, Albacete, Spain

[9] Hosp Clin Univ Valladolid, Valladolid, Spain

[10] Hosp Univ Nuestra Senora Sonsoles, Avila, Spain

[11] Hosp Univ Infanta Leonor, Madrid, Spain

[12] Hosp Sierrallana, Torrelavega, Cantabria, Spain

[13] Hosp Univ Severo Ochoa, Madrid, Spain

[14] Hosp Rio Carrion, Palencia, Spain

[15] Hosp Univ Rio Hortega, Valladolid, Spain

[16] Hosp Gen Segovia, Segovia, Spain

[17] Hosp Santa Barbara, Soria, Spain

[18] Hosp Univ San Cecilio, Granada, Spain

[19] Hosp Univ La Plana, Villareal, Castellon, Spain

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[21] Efficacy and safety of inclisiran in real-world clinical practice. Results from the CHOLINET Registry
Gargiulo, P.
Fontanarosa, S.
Marzano, F.
Cotticelli, C.
Crisci, M.
Marcucci, R.
Maloberti, A.
Sarullo, F. M.
Galasso, G.
Musumeci, G.
Indolfi, C.
Varbella, F.
Calabro', P.
Carugo, S.
Perrone-Filardi, P.
EUROPEAN HEART JOURNAL, 2024, 45
[22] Characterising the safety and use of C1 inhibitor in routine clinical practice: interim results from a European Registry study
Aygoeren-Puersuen, E.
Magerl, M.
Martinez-Saguer, I
Longhurst, H.
Caballero, T.
Strassen, U.
Staubach, P.
Martin, L.
Maurer, M.
Hamdani, M.
Andresen, I
ALLERGY, 2015, 70 : 252 - 252
[23] Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice in France - Interim Results From a Large Observational Study
Quittet, Philippe
Hamidou, Mohamed
Bonnotte, Bernard
Fain, Olivier
Dillingham, Kerry
Kreuzbauer, Georg
BLOOD, 2012, 120 (21)
[24] ROMIPLOSTIM FOR THE TREATMENT OF ADULTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN ROUTINE CLINICAL PRACTICE - INTERIM RESULTS FROM A LARGE, EUROPEAN, OBSERVATIONAL STUDY
Wadenvik, H.
Steurer, M.
Janssens, A.
Quittet, P.
Kaiafa, G.
Kozak, T.
Papadaki, H.
Selleslag, D.
Dillingham, K.
Kreuzbauer, G.
HAEMATOLOGICA, 2012, 97 : 252 - 252
[25] Romiplostim for the treatment of adults with primary Immune Thrombocytopenia (ITP) in routine clinical practice in Germany - Interim results from an observational study (PLATEAU)
Welstau, M.
Reiser, M.
Illmer, T.
Schlag, R.
Josten, K.
Dietzfelbinger, H.
Tschechne, B.
Schaffrik, M.
Soelch, J-P
ONKOLOGIE, 2012, 35 : 223 - 223
[26] Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice - Interim Results From a Large, European, Observational Study
Selleslag, Dominik
Janssens, Ann
Wadenvik, Hans
Steurer, Michael
Quittet, Philippe
Kaiafa, Georgia
Kozak, Tomas
Papadaki, Helen
Viallard, Jean-Francois
Dillingham, Kerry
Kreuzbauer, Georg
BLOOD, 2012, 120 (21)
[27] Safety and Clinical Efficacy of Sideguard® Stent for Treatment of Bifurcation Lesions: Interim Results from the European Sideguard® Bifurcation Registry Study
Fath-Ordoubadi, Farzin
Hauptmann, Karl-Eugen
Latib, Azeem
Eccleshall, Simon
Menown, Ian
Egred, Mohaned
Spyrou, Nicos
Sivananthan, Mohan
Mamas, Mamas
Sastry, Sanjay
Iqbal, Javed
Witherow, Fraser
Grech, Ever
Mills, Joseph
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B201 - B201
[28] Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice
Ptushkin, V. V.
Vinogradova, O. Yu.
Pankrashkina, M. M.
Chernikov, M. V.
Arshanskaya, E. G.
Tkachenko, N. E.
TERAPEVTICHESKII ARKHIV, 2018, 90 (07) : 70 - 76
[29] Safety and Efficacy of Romiplostim in over 200 Children with Immune Thrombocytopenia (ITP): Results of an Integrated Database of 5 Clinical Trials
Tarantino, Michael D.
Despotovic, Jenny M.
Roy, John
Grainger, John
Cooper, Nichola
Beam, Donald
Raj, Ashok
Maschan, Alexey A.
Kim, June
Eisen, Melissa Jeanne
BLOOD, 2018, 132
[30] Safety and efficacy of self-administered romiplostim in patients with immune thrombocytopenia: Results of an integrated database of five clinical trials
Kuter, David J.
Arnold, Donald M.
Rodeghiero, Francesco
Janssens, Ann
Selleslag, Dominik
Bird, Robert
Newland, Adrian
Mayer, Jiri
Wang, Kejia
Olie, Robert
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (06) : 643 - 651

← 1 2 3 4 5 →